1 insider bought €2,577 of shares over the last 90 days, the latest by 이상준, filed 19 Aug 2026.
From Bio Co.,Ltd: what insiders have been doing
This page follows insider dealings at From Bio Co.,Ltd as filed with DART (FSS), a company from the Health Care sector. In the past year (30 October 2025 to 30 October 2026), 8 filings came from 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 3 purchases. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 board member and 1 chief executive.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 8 filings here. Looking back to 2021, when coverage begins, insiders filed 18 purchases and no sales.
The last purchase on record was published on 19 August 2026, which is 82 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 4 days. That lag is the time during which only the insider knows about the trade.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 1,382 sharesShareKRXDART:20260819000315Canonical exit: 17 Nov 2026 (T+90)
- Other0DART
- 150,000 sharesShareKRXDART:20260702000459Canonical exit: 30 Sept 2026 (T+90)
- ShareKRXDART:20260701000035
- 130,000 sharesShareKRXDART:20260609000170Canonical exit: 7 Sept 2026 (T+90)
- 0KRXDART:20260206001610
- 0KRXDART:20251222000076
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20241227000188
- 152,897 sharesShareKRXDART:20241106000031Canonical exit: 4 Feb 2025 (T+90)
- 292,999 sharesKRXDART:20241106000034Canonical exit: 29 Jan 2025 (T+90)
- 140,102 sharesShareKRXDART:20241023000052Canonical exit: 21 Jan 2025 (T+90)
- ShareKRXDART:20241015000017Canonical exit: 5 Jan 2025 (T+90)
- 575,000 sharesKRXDART:20241011000095Canonical exit: 31 Dec 2024 (T+90)
- ShareKRXDART:20240905000053
- ShareKRXDART:20240903000031Canonical exit: 27 Nov 2024 (T+90)
- 163,600 sharesKRXDART:20240409000395Canonical exit: 24 Jun 2024 (T+90)
- ●Executives0DART
- 575,000 sharesKRXDART:20231227000398Canonical exit: 18 Mar 2024 (T+90)
- 575,000 sharesKRXDART:20231218000209Canonical exit: 14 Mar 2024 (T+90)
- 575,000 sharesKRXDART:20231129001327Canonical exit: 21 Feb 2024 (T+90)
- 575,000 sharesKRXDART:20231017000196Canonical exit: 10 Jan 2024 (T+90)
25 of 34 declarations
About From Bio Co.,Ltd
FromBio is a South Korean biotechnology company listed on XKRX, focusing on the development of innovative biopharmaceuticals.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
